Vertex(VRTX) - 2024 Q1 - Quarterly Results

Vertex Reports First Quarter 2024 Financial Results First Quarter 2024 Results Product revenue increased 13% to $2.69 billion compared to the first quarter of 2023, primarily driven in ex- U.S. markets by the continued strong uptake of TRIKAFTA /KAFTRIO , including label extensions in younger age groups, and in the U.S. by the continued performance of TRIKAFTA, including the uptake in children with CF 2 to 5 years of age. Net product revenue in the first quarter of 2024 increased 8% to $1.52 billion in the ...